NL-OMON26423已完成不适用
Ketoacid ingestion along with protein to attenuate muscle catabolism during hemodialysis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Aged >18 years
- •-Ability to provide written informed consent
- •-Hemodialysis treatment for >3 months
- •-Well-functioning arteriovenous shunt in upper or lower arm
排除标准
- •-Hospitalization <1 months prior to study period
- •-Missed hemodialysis procedure <1 month prior to study period
- •-Active inflammatory disease / malignancies
- •-Uncontrolled hypertension (>200/100mm Hg) or arrhythmia
- •-Previous episodes of intradialytic hypotension related to food intake
- •-Allergies to milk proteins
- •-Dysphagia
- •-Pregnancy
- •-Cognitive disorders
研究者
相似试验
已完成
不适用
Ketoacid ingestion along with protein to attenuate muscle catabolism during hemodialysisEiwitmetabolisme in het hele lichaamMuscle wastingprotein-energy wasting syndrome10028302NL-OMON51089niversiteit Maastricht12
进行中（未招募）
不适用
Can a ketone drink reduce the severity of symptoms of Parkinson’s disease?Parkinson's diseaseISRCTN64294760TdeltaS Ltd20
已完成
不适用
Can a ketone drink increase ATP in the brains of patients with Parkinson's disease?ISRCTN10531043TdeltaS Ltd10
已完成
不适用
The effect of exogenous ketone salt supplement intake on the oral glucose tolerance testJPRN-UMIN000034088Sportology Center, Juntendo University15
进行中（未招募）
1 期
Impact of low protein diet supplemented with ketoanalogues on uremic toxins production and glucose metabolism in chronic kidney disease_KETO GUT studyMedDRA version: 20.0Level: LLTClassification code 10076412Term: Chronic kidney disease stage 5System Organ Class: 100000004857MedDRA version: 20.0Level: LLTClassification code 10076411Term: Chronic kidney disease stage 4System Organ Class: 100000004857chronic kidney diseaseEUCTR2019-002225-30-FRHospices Civils de Lyon85